LSLiang Shan

Liang Shan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Liang Shan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Chao He

    School of pharmaceutical sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China

    1 shared publication
  • Chaoling Dong

    Division of General Internal Medicine and Population Science, Department of Medicine, University of Alabama at Birmingham , Birmingham, Alabama

    1 shared publication
  • D. Minassian

    Medical Scientist Training Program, University of Alabama at Birmingham, Birmingham, AL, United States

    1 shared publication
  • Fei Guo

    Department of Intensive Care Medicine The Affiliated Hospital of Qingdao University Qingdao 266003 China

    1 shared publication
  • Ling Feng Pan

    Department of Intensive Care Medicine The Affiliated Hospital of Qingdao University Qingdao 266003 China

    1 shared publication
  • Min Mao

    Department of Intensive Care Medicine The Affiliated Hospital of Qingdao University Qingdao 266003 China

    1 shared publication

Latest Publications

  • Improved Anticoagulant Effect of Layered Double Hydroxide‐Heparin Nanocomposites on the Microcirculation of Septic Rats

    by Min Mao, Yan Sheng Shan, Xiao Meng Wang, Pei Yu Guo, Fei Guo, Ling Feng Pan, Zi Dan Wang, Zhi Ping Xu, Qi Hui Zhou, Liang Shan

    Anticoagulant therapy is an important therapeutic tool for septic microcirculatory dysfunction. Low molecular weight heparin (LMWH) is a potent anticoagulant with antithrombotic properties, which is a crucial factor for sepsis treatment. However, it has a short plasma half‐life and achieves low local concentrations; nanocomposite formulations may help overcome these limitations. Herein, it is aimed to determine if a functional layered double hydroxide (LDH)–LMWH nanocomposite improves microcirculation and organ function, while maximizing the antithrombotic effects and reducing bleeding risks in septic rats. This nanocomposite (fluorescein isothiocyanate (FITC)–fibrin antibody (Ab)–bovine serum albumin (BSA)–20LMWH–LDH) is constructed by intercalating LMWH and FITC into the LDH interlayer, and application of a BSA and an Ab coating onto the LDH nanoparticle surface. The nanocomposite released LMWH in a gradual and biphasic pattern, in an acidity‐triggered manner. Capillary tubule studies and intestinal microcirculation investigations show that green fluorescent nanocomposites accumulated around microthrombi, validating their targeting ability. Animal experiments reveal that the nanocomposites significantly improve microcirculation in septic rats with minimal pathological damage to the heart, lung, liver, and kidney tissues. Thus, this study provides a novel strategy for the treatment of septic microcirculatory dysfunction in clinical situations.